GENDER FEATURES OF THE DEVELOPMENT OF CARDIOVASCULAR RISKS IN HIV-INFECTED PATIENTS NOT RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
- Authors: CHUKAEVA I.I.1, KRAVCHENKO A.V2, KOMAROVA I.V1, KUSHAKOVA T.E2, SAINO O.V1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University
- Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
- Issue: No 4 (2013)
- Pages: 59-64
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/276971
- ID: 276971
Cite item
Open Access
Access granted
Abstract
HIV infection is a recognized risk factor for cardiovascular diseases. The role of maleness in HIV-infected patients has not been adequately studied. Objective. To estimate the magnitude of traditional risk factors in HIV-infected patients of both sexes with the natural course of HIV infection. Subjects and methods. Twenty-one patients with the natural course of HIV infection without cardiovascular diseases (a study group) were examined. The mean count of CD4+ lymphocytes was 399.05±159.47 cells/ml. A control group comprised 39 patients without HIV infection and cardiovascular diseases. The blood level of total cholesterol (TC), low-density lipoproteins (LDL), very low-density lipoproteins (VLDL), high-density lipoproteins (HDL), triglycerides (TG), glucose, insulin, tumor necrosis factor-a (TNF-а), interleukin (IL)-12, and IL-18 were determined in all the patients. The plasma concentrations of TC, LDL, VLDL, HDL, TG, apolipoprotein B, and glucose were estimated by an Architect ci8200 biochemical autoanalyzer. The level of insulin was determined by an Immulite 2000 biochemical autoanalyzer. That of TNF-a, IL-12, and IL-18 was estimated by enzyme immunoassay using the standard plates. Results. The women with the natural course of HIV infection were found to have significantly higher TC, LDL, and HDL levels than in the HIV-infected men. The men with the natural HIV infection had also a significantly lower level of these parameters than those from the control group. Conclusion. Using the findings, it may be assumed that HIV infection erases gender differences in the development of cardiovascular risk factors, such as TC and LDL levels.
Keywords
Full Text
About the authors
Irina I. CHUKAEVA
N.I. Pirogov Russian National Research Medical University
Email: chukaeva@mail.ru
Moscow
A. V KRAVCHENKO
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: alexey-kravtchenko@yandex.ru
Moscow
I. V KOMAROVA
N.I. Pirogov Russian National Research Medical University
Email: irka.komarova@gmail.com
Moscow
T. E KUSHAKOVA
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: tatyanaq@mail.ru
Moscow
O. V SAINO
N.I. Pirogov Russian National Research Medical University
Email: Osayno@yandex.ru
Moscow
References
- Сметник В.П., Сметник А.А. Женские половые гормоны и сердечено-сосудистая система. Медицинский совет 2011; 3-4: 40-45.
- Mendelsohn M.E., Karas R.H. Mechanisms of disease: The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999; 340: 1801-1811.
- Losordo D.W., Kearney M., Kim E.A. et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-1510.
- Post M.S., Verhoeven M.O., van der Mooren M.J. et al. The effect of HRT on plasma levels of the cardiovascular risk factor ADMA; A randomized placebo-controlled 12-week study in healthy early postmenopausal women. J. Clin. Endocrinol. Metab. 2003; 88: 4221-4226.
- Kovanen P.T., Brown M.S., Goldstein J.L. Increased binding of LDL to liver membranes from rats treated with 17|3-ethinyl estradiol. J. Biol. Chem. 1979; 254: 1136711373.
- Tikkanen M.J., Nikkia E.A., Kuusi T. et al. HDL-2 and hepatic lipase; Reciprocal changes produced by estrogen and norgestrel. J. Clin. Endocrinol. Metab. 1982; 54: 1113-1117.
- Freedman D.S., Jacobsen S.J., Barboriak J.J. et al. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 1990; 81(5): 1498-1506.
- Meilahn E.N., Kuller L.H., Mathews K.A. et al. Hemostatic factors according to menopausal status and use of hormone replacement therapy. Ann. Epidemiol. 1992; 2: 445-455.
- Sites C.K., Toth M.J., Cushman M. et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil. Steril. 2002; 77: 128-135.
- Cioffi M., Esposito K., Vietri M. et al. Cytokine pattern in postmenopause. Maturitas 2002; 41: 187-192.
- Triant V.A. HIV and Cardiovascular Disease. HIV/AIDS Annual Update, 2010.
- Чукаева И.И., Комарова И.В., Кравченко А.В. и др. ВИЧ как независимый фактор риска сердечно-сосудистых заболеваний. Эпидемиол. инфекц. болезни. Актуал. вопр. 2012; 4: 22-27.
- Kaplan C.R., Kingsley L.A., Sharrett A.R. et al. Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women. Clin. Infect. Dis. 2007; 45 (8): 1074-1081.
- Gwarzo U., Maji T., Isa-Dutse S. et al. Cardiovascular disease risk factor profiles of HIV-positive clients: findings from a pilot program to integrate CVD screening into HIV services at a secondary health facility in Kano, North-Western Nigeria. XIX International AIDS Conference (AIDS 2012). Washington DC, USA. 22-27 July 2012.
- Чукаева И.И., Кравченко А.В., Комарова И.В. и др. Роль факторов риска в развитии сердечно-сосудистой патологии у ВИЧ-инфицированных пациентов с естественным течением ВИЧ-инфекции. Эпидемиол. инфекц. болезни. Актуал. вопр. 2013; 2: 76-80.
- Fuentes B., Garces M.C., Diez Tejedor E. et al. Endothelial dysfunction markers in stroke patients. Cerebrovasc. Dis. 2002; 13 (Suppl 3): 31.
- Parrinello C.M., Landay A.L., Hodis H.N. et al. Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women’s Interagency HIV study. Atherosclerosis 2012; 225(2): 408-411.
- Reingold J.S., Wanke C., Kotler D.P. et al. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) study. J. Acquir. Immune Defic. Syndr. 2008; 48: 142.
- Lane B.R., Markovitz D.M., Woodford N.L. et al. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 1999; 163(7): 3653-3661.
Supplementary files
